Donate For Public and Patients Store Search

Welcome!

Search


American Academy of Dermatology Association Applauds Introduction of The Patients First Act Aimed at Medicare Physician Reform

Statement from Murad Alam, MD, MSCI, MBA, FAAD, President, American Academy of Dermatology Association ROSEMONT, Ill. (July 15, 2026) — The American Academy of Dermatology Association applauds Academy member Representative John Joyce, MD, FAAD (R-PA), for introducing bipartisan, comprehensive Medicare physician payment reform legislation, the Patients First Act. The Academy

This month’s news from across the specialty

What’s hot ... September 1, 2022 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Bryan Carroll, MD, PhD, FAAD What’s Hot? Capsaicin! The popular spice has been shown to decrease inflammation through a mechanism that is independent

This month's news from across the specialty

What's hot ... April 1, 2021 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Mallory Abate ... Mallory Abate, MD Differentiating BCCs from intradermal nevi (IDN) along the lower eyelid margin can be tricky, but is important

Session handouts and meetings archive

View previous AAD meeting sessions, handouts, poster exhibits, and floor plans.

A sweeter approach to treating scleroderma?

We’re like licorice. Not everybody likes licorice, but the people who like licorice really like licorice – Jerry Garcia. Patients with scleroderma may learn to love licorice.

Home at last

My mother has talked of her demise for years, but usually in the context of challenging medical dogma in her will to live – having surgeries (cervical spine repair, ostomy reversal) and procedures performed that were considered too risky for the aged – “It’s all about quality of life. I’d

CME & session evaluation archive

Claim CME credit and submit session evaluations for attending previous Academy meetings.

AADA hosts largest Capitol Hill skin cancer check in a decade

On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.

Academy physician leaders meet with federal legislators

On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform.

Weighing in on glucagon-like peptide-1 receptor agonists in dermatology

Glucagon-like peptide-1 (GLP-1) receptor agonists are now approved for weight loss, which may benefit dermatoses associated with excess weight. Dermatologists should be familiar with the potential adverse effects and benefits of these drugs.

AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair

Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health

Progress in pemphigus: Solidifying rituximab’s role

Read the July 7, 2021 DermWorld Insights and Inquiries on solidifying rituximab’s role in pemphigus treatment.

Rituximab therapy for recalcitrant dermatitis herpetiformis: A gut feeling

Recently I “accidentally” diagnosed a severely pruritic man with dermatitis herpetiformis (DH). He had seen leading authorities for his life-altering pruritic dermatosis, that clinically and histologically was an eczematous eruption.

Deeper thoughts about acne keloidalis nuchae

DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, February 1, 2026 Vol. 8, No. 2 Wallace Clark taught me the truism that thinking often ceases when a diagnosis is rendered. The clinical diagnosis of acne keloidalis nuchae (AKN) is straightforward. Embarrassingly, I had not given much thought

Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon

Read the Aug. 17, 2022 DermWorld Insights and Inquiries on cutaneous lupus erythematosus and interferon.

DermWorld: Your go-to practice, policy, and care resource

This year, we asked hundreds of members what they thought about the Academy’s flagship publication, DermWorld, and the results are in.

Advocacy Update June 30, 2026

AADA President Murad Alam, MD, MSCI, MBA, FAAD, met with federal legislators on Medicare physician payment reform in Washington, DC.

Advocacy Update Feb. 4 2025

The AADA is pleased that physician champions in the U.S. House introduced a bipartisan bill to address the 2025 Medicare Physician Fee Schedule cut.

Advocacy Update May 5, 2026

In response to advocacy by the AADA and other specialty societies, UnitedHealth Care will delay any adverse payment decisions related to Medicare Advantage referral requirements starting on May 1.

Advocacy Update Dec 9, 2025

The AADA endorsed a House bill that would include an annual inflationary update to the Medicare physician fee schedule, the Academy’s top federal advocacy priority.

Taking the challenge: Social media, adolescents, and the skin

Learn more about Taking the challenge: Social media, adolescents, and the skin at aad.org

High-dose vitamin D may be a ray of sunshine for treating sunburn

High-dose vitamin D, which has shown benefit in toxic erythema of chemotherapy and acute radiation dermatitis, may also be helpful for treating sunburn.

Advocacy Update Feb. 18 2025

The AADA joined over 130 national and state physician organizations led by the AMA demanding Congress act to reform Medicare physician payment.

Advocacy Update July 21, 2026

New legislation introduced would modernize the Medicare physician payment system.

Advocacy Update July 28, 2026

President’s message on Academy’s efforts on fighting proposed Dermatology cuts.

Advocacy Update Mar. 18, 2025

The AADA is outraged that Congress once again passed a government funding bill that did not include relief to stop this year’s 2.8% Medicare physician payment cut.

April 7, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 7, 2021 ... Applying 2021 E/M coding concepts in everyday practice – Part 2 DermWorld Insights and Inquiries : Keeping an eye on melanoma AAD collaborates with OM1 to enhance

Brentuximab vedotin update and the #MeToo saga of the Reed-Sternberg cell

There has been increasing dermatological literature about the use of brentuximab vedotin (BV) for a variety of CD30+ cutaneous lymphomas. The thrust of this commentary is to examine the current reports about BV.

Primary sclerosing cholangitis associated with pyostomatitis vegetans and pyodermatitis vegetans: A potentially bilious situation

Inflammatory bowel disease may be associated with multiple cutaneous manifestations including pyoderma gangrenosum (PG), erythema nodosum, or directly by fistulae or “metastatic” Crohn disease.

I’ll have a necrobiotic xanthogranuloma to go – with mustard!

Mechlorethamine has been used for decades to treat cutaneous T cell lymphoma. Rodriguez et al utilized 0.01% topical nitrogen mustard to treat a 60+ year-old man with biopsy-proven NXG with paraproteinemia (IgG-κ), without myeloma.

Glucose monitors: Not as sweet as they seem

Learn more about Glucose monitors: Not as sweet as they seem at aad.org

Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome

Read the June 17, 2020 DermWorld Insights and Inquiries on capillary malformation.

Beyond disfigurement: The potential for keratinocyte carcinoma in discoid lupus erythematosus

Rarely, life-threatening squamous cell carcinomas may complicate discoid lupus erythematosus (DLE). Securing the diagnosis of keratinocyte carcinoma (squamous cell carcinoma more likely than basal cell carcinoma) within DLE may be challenging. Preliminary evidence suggests that treating DLE may decrease the risk of malignancy.

This month's news from across the specialty

What's hot ... March 1, 2021 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Craig Burkhart, MD, MPH, MSBS The American Journal of Public Health published a series of analyses on wasteful spending in United States health

Academy publications continue to top the charts!

We are your go-to source for navigating practice, policy, and patient care. Last year, we asked hundreds of members what they thought about the Academy’s flagship publication, DermWorld, and the results are in.

You like tomato, I like tomahto, you soak with steroids, I use them dry…

I have been a firm believer in the “Soak and Smear” approach to treating recalcitrant dermatoses, including atopic dermatitis, as detailed by Gutman et al, more than a decade ago.

Recognizing Trichophyton indotineae

In the last decade, a recently emerged dermatophyte species, Trichophyton indotineae, has been causing major outbreaks of severe, difficult-to-treat, and frequently relapsing infections in South Asia among immunocompetent patients.

September 25

Learn more about September 25 at aad.org

Key messages to communicate about Indoor tanning

By communicating these key messages on indoor tanning, you can help position the specialty while increasing your credibility and raising the profile of your practice.

Rapalogs for vascular lesions: Caveat mTOR

Rapalogs are drugs that inhibit the mTOR pathway and include sirolimus (rapamycin), temsirolimus, everolimus, and deforolimus. All are immunosuppressive and have antineoplastic/antiproliferative effects.

Perianal dermatologic exams are looking up

Every dermatologist confronts how to ask a person to disrobe for a full body skin examination. Ultimately, I came up with the following line when asked what should be exposed: “The more of you I see, the better off you are – please get undressed to your level of comfort”.

Advocating on behalf of dermatology is an enduring obligation

From the President ... Dr. Hruza served as Academy president from March 2019 to March 2020. ... By George Hruza, MD, MBA, December 1, 2019 The year is winding down, and as usual I find myself reminiscing about the last 12 months — thinking about all of the patients I

February 21

Learn more about February 21 at aad.org

Melanoma Reporting — Measure 397

Access reporting information on measure 397: Melanoma Reporting. Review the maximum points available, the measure type, measure specifications, and much more.

Melanoma Reporting — Measure 397

Access reporting information on measure 397: Melanoma Reporting. Review the maximum points available, the measure type, measure specifications, and much more.

AMA introduces new prolonged service code for 2021

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, manager, coding and reimbursement, January 1, 2021 Academy coding staff address important coding topics each month in Derm Coding Consult. ... Read more Derm Coding Consult articles . Coding based on time ... As previously discussed

April 20, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 20, 2022 ... Which biologics are most effective for psoriasis? DermWorld Insights and Inquiries : One Toker over the line — Clarifying Toker cell hyperplasia in Zuska disease and its

Diagnosing infectious diseases in 2028: Let the good times roll

You may be overwhelmed by the “omics” – genomics, epigenomics, transcriptomics, proteomics, metabolomics, with good reason. “Big Data” are changing the diagnostic landscape in infectious diseases and oncology at breakneck speed. Warning: By the time this is posted, it may be obsolete!

Old stains leaving new marks in dermatology

Dermatologists are often confronted by patients who simply cannot afford prescription medications. Repurposed, inexpensive drugs for new indications are satisfying both medically and economically. The “rediscovery” of gentian violet is such an agent.

Understanding the risk of Wilms Tumor in hemihypertrophy: Are we halfway there?

Wilms tumor (WT, nephroblastoma) is the most common pediatric renal cancer, characteristically found in children younger than 5 years old. When should dermatologists be concerned?

Viva ex vivo dermoscopy?

It has been said that the best “special stain” is a deeper section – wise words indeed. While always gratifying to discover pathology not present on original sections, it is also humbling to ponder the number of incorrect diagnoses because deeper sections are not obtained.

Taming toxic erythema of chemotherapy with high-dose vitamin D

Toxic erythema of chemotherapy (TEC) is the umbrella term for multiple eruptions caused by chemotherapeutic agents. TEC may last for up to a month. Although confirmatory studies are warranted, research suggests that the anti-inflammatory action of high-dose vitamin D may be of therapeutic value in TEC.

Biotin supplementation for hair and nail health: Does it pass the test?

Read the November 17, 2021 DermWorld Insights and Inquiries on biotin supplementation for hair and nail health.

After 23 years, a syndrome converted me into an eflornithine believer

Polyamines are integrally involved with the hair cycle. The Bachmann-Bupp syndrome has shed new light on the role of ornithine decarboxylase, and how it’s inhibition by eflornithine can be used as an advantage to either slow or stimulate hair growth.

This month’s news from across the specialty

What’s hot ... December 1, 2024 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Craig Burkhart, MD, MS, MPH, FAAD More than 80% of prior authorization appeals are overturned. Insurance plans’ most common interventions to manage utilization

Obituaries

Obituaries ... By Jerry Graff, MD, June 3, 2019 The Academy recently learned with sorrow of the passing of the following members of the dermatologic community. ... JON GARRY BEIDLER, MD, of Chambersburg, Pennsylvania, Dec. 30, 2018, at age 82. Trained in dermatology at University of Pennsylvania and practiced in

July 24

Learn more about July 24 at aad.org

January 24

Learn more about January 24 at aad.org

December 18, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / December 18, 2024 ... Combined topical 5-FU and calcipotriene for superficial keratinocyte carcinomas DermWorld Insights and Inquiries : Holiday greeting 2025 FDA approves tapinarof cream for atopic dermatitis Upadacitinib vs. dupilumab

Untangling the neurologic comorbidities of bullous pemphigoid

Comorbidities are the darlings of the dermatologic literature in the 21st century, based on an epidemiologic ability to sort through vast databases, finding associations and correlations that may or may not have direct clinical relevance.

When the physician becomes the patient

Physicians with disabilities discuss what it’s like practicing medicine and how their experiences help shape patient care. ... Feature ... By Alllison Evans, Assistant Managing Editor, October 1, 2024 Physicians are well practiced in caring for people with chronic illnesses and disabilities — both those that are visible and invisible.

This month's news from across the specialty

What's hot ... October 1, 2021 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Mallory Abate, MD, FAAD We all know how frustrating it can be when a patient’s acne returns after isotretinoin, requiring them to undergo

May 7, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 7, 2025 ... Low-dose oral minoxidil vs. combination therapy with dutasteride or finasteride DermWorld Insights and Inquiries : Getting a head up on cutaneous scalp malignancies Academy mourns the passing

Selecting an EHR

Each year, the MIPS requirements become more stringent, and exemptions may no longer be offered. The Academy advises dermatologists who wish to participate in MIPS to adopt an EHR now.

DermWorld physician editor search

The American Academy of Dermatology’s award-winning monthly magazine, DermWorld, seeks candidates to serve as its next paid physician editor.

Tarrying for tapinarof

Read the January 12, 2022 DermWorld Insights and Inquiries on tapinarof.

This month’s news from across the specialty

What’s hot ... February 1, 2025 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Craig Burkhart, MD, MS, MPH, FAAD The Nation’s Health by the American Public Health Association published a ... special report on improving health

This month’s news from across the specialty

What’s hot ... March 1, 2023 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Bryan Carroll, MD, PhD, FAAD New, but not new, but maybe new, but not good = ... Candida auris is looking worse with

April 28, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 28, 2021 ... Acne: Clindamycin-tretinoin vs. benzoyl peroxide-adapalene DermWorld Insights and Inquiries: Do not get burned by missing Staphylococcal scalded skin syndrome Is daylight photodynamic therapy effective for actinic keratosis?

October 2, 2019

Learn more about October 2 at aad.org

May 11, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 11, 2022 ... Sexual dysfunction associated with finasteride use in men with androgenetic alopecia DermWorld Insights and Inquiries : Lagging ahead — LAG-3 checkpoint inhibition for advanced melanoma FDA grants

December 18, 2019

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / December 18, 2019 ... Which physicians were sued most in 2019? DW Insights and Inquiries: Holiday greeting 2020 — eyeing dermatology’s future New DW Academy Insider coming in 2020 Does teledermatology

March 27, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 27, 2024 ... Spironolactone: Risk of breast, gynecologic malignancies? DermWorld Insights and Inquiries : Always another worry for patients with hidradenitis suppurativa — Amyloid A amyloidosis FDA approves spesolimab for

Oy, another “Oid” to worry about: Cryptococcoid lesions

Learn more about Oy, another “Oid” to worry about: Cryptococcoid lesions at aad.org

This month’s news from across the specialty

What’s hot ... June 1, 2023 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Christen Mowad, MD, FAAD The American Academy of Dermatology SPOT Skin Cancer™ program has been very well received and provides a community service

This month’s news from across the specialty

What’s hot ... March 1, 2026 In this monthly column, members of the  DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty.   Harry Dao Jr., MD, FAAD Injectable biologics remain the gold standard for achieving optimal clinical responses in psoriasis, but fear of injections leads many

MIPS 2020 is here. Here are the highlights

Answers in Practice ... Faiza Wasif, MPH, is the AAD's practice management manager. Her column offers tips on an area she commonly receives questions about from members. ... By Faiza Wasif, MPH, April 1, 2020 Each month Dermatology World ... tackles issues "in practice" for dermatologists. This month Faiza Wasif,

May 5, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 5, 2021 ... Is dutasteride an effective treatment for frontal fibrosing alopecia? DermWorld Insights and Inquiries : Digging deeper into lupus erythematosus panniculitis Which herbal supplements may affect autoimmune skin

COVID-19 dermatology registry

The Academy is bringing together dermatologists to report on the dermatologic manifestations of COVID-19. This anonymous reporting registry is helping the Academy gather and disseminate important information regarding the infection and how it impacts patients.

A future therapeutic Harlequin Romance?

My fiancé Ronnie, then a pediatric resident, called me excitedly, asking for my opinion about a remarkable neonate that was just delivered at Elmhurst Hospital. I was at our dermatology resident clinic in Van Etten Hospital, and recited her description of a newborn (large plates of creamy brown scale, fissures,

Mental health cases in pediatric dermatology

Go to AAD Home ... Go to AAD Home ... Menu ... Experts discuss the cutaneous manifestations of Munchausen by proxy, child abuse, and eating disorders ... Experts discuss the cutaneous manifestations of Munchausen by proxy, child abuse, and eating disorders ... By Barbara Boughton, contributing writer While most dermatologists

The nexus of VEXAS syndrome

Read the December 1, 2021 DermWorld Insights and Inquiries on VEXAS syndrome.

Tackling Stevens-Johnson syndrome/toxic epidermal necrolysis: Part 2

Controversies and management ... Feature ... By Emily Margosian, Senior Editor, June 1, 2026 How would you treat a confirmed case of Stevens-Johnson Syndrome (SJS)/toxic epidermal necrolysis (TEN)? ... Corticosteroids ... Cyclosporine ... Intravenous immunoglobulin (IVIG) ... A tumor necrosis factor (TNF) inhibitor ... A combination of the above ...

Summary of MIPS 2021 changes

Answers in Practice ... By Faiza Wasif, MPH, manager, practice management, February 1, 2021 Each month DermWorld ... tackles issues "in practice" for dermatologists. This month Faiza Wasif, MPH, the Academy’s Practice Management manager, offers a summary of MIPS changes in 2021. CMS released the final Quality Payment Program (QPP)

This month's news from across the specialty

What's hot ... October 1, 2020 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... ED COWEN, MD Why do a small percentage of young and apparently healthy patients with COVID-19 develop life-threatening infection or a Kawasaki syndrome-like

This month’s news from across the specialty

What’s hot ... December 1, 2022 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Harry Dao Jr., MD, FAAD One advantage of working in the same practice as your surgeons is the ability to quickly confirm biopsy

Diagnosing the primary cutaneous SMARCA4-deficient cutaneous tumor: You don’t know what you got ‘til it’s gone

Dermatologists may rarely encounter SMARCA4-deficient undifferentiated malignant neoplasms, either as primary cutaneous tumors or as metastatic lesions.

August 1

Learn more about August 1 at aad.org

September 29, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 29, 2021 ... Is HPV vaccination associated with clearance of common warts? DermWorld Insights and Inquiries : Positively perplexing — Determining the meaning of CD30 positivity FDA proposes new guidance

Professionalism and Ethics

The AAD’s Professionalism and Ethics Committee has proposed a five-part voluntary statement, now ratified by the AAD Board of Directors. The statement sets the basic framework for an ethical practice; it is not designed to set unattainable or unrealistic standards. As such, it is hoped that AAD members will strive

Getting a head up on cutaneous scalp malignancies

Cutaneous scalp malignancies are common in patients with alopecia. Research suggests hair prevents carcinogenesis by physically blocking ultraviolet light and other mechanisms.

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226

Access reporting information on measure 226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention. Review the maximum points available, the measure type, a measure flowchart, measure specifications, and much more.

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226

Access reporting information on measure 226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention. Review the maximum points available, the measure type, a measure flowchart, measure specifications, and much more.

Time to reassess messing around with steroids and psoriasis

Read the March 3, 2021 DermWorld Insights and Inquiries on reassessing steroids and psoriasis.

Getting steamed over vaping

Read the January 29, 2020 DWII on vaping and the skin.

HIV 40th anniversary: An oral history

Reflecting on dermatology’s contributions to the investigation and treatment of HIV/AIDS ... Feature ... By Emily Margosian, assistant editor, June 1, 2021 As the world continues to wrestle with the aftershocks of COVID-19, this June marks the 40th anniversary of another deadly virus. Since its first identification in the summer

A tug of war

The AADA continues to make headway against scope of practice threats. ... Feature ... By Allison Evans, Assistant Managing Editor, September 1, 2024 The tug of war for scope expansion continues. As both sides are poised to pull the rope — and with it the opposing team — across the

January 26, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 26, 2022 ... Allergens in hand sanitizers DermWorld Insights and Inquiries : Eccrine syringofibroadenoma — Sweating over the details Derm Coding Consult : Applying 2021 E/M coding concepts in everyday

The profound dermatological manifestations of COVID-19: Part VII — Who was that masked man?

Read the September 23, 2020 Derm World Insights and Inquiries on COVID-19 and masks.

Targeted anti-complement therapy may prove to be a complementary treatment for bullous pemphigoid

Read the October 7, 2020 DermWorld Insights and Inquiries on targeted anti-complement therapy for bullous pemphigoid.

Eosinophilic dermatosis of hematologic malignancy: Reality bites

Learn more about Eosinophilic dermatosis of hematologic malignancy: Reality bites at aad.org

Reassuring patients with sclerosing lymphangitis of the penis that they will not get shafted

Sclerosing lymphangitis of the penis may be anxiety-provoking but is a self-limited disorder that characteristically resolves within weeks without residual complications.

Homing in on hornerin: Breaking down the barrier to understand its crucial role in atopic dermatitis

Maintaining the skin barrier is crucial in managing patients with atopic dermatitis. The pathomechanism(s) of barrier impairment is complex and integrally associated with immune dysregulation. Research on newly discovered proteins in the stratum corneum, such as hornerin, may lead to novel therapeutic interventions.

Trichobacteriosis: A salute to the Shelleys

Trichobacteriosis is the more accurate name for the corynebacterial infection with the misnomer of trichomycosis axillaris.

The malignant risk in circumscribed palmar or plantar hypokeratosis: Summoning Charles Dickens and Freddie Mercury

There is a small risk for developing keratinocyte carcinomas in circumscribed palmar or plantar hypokeratosis. Patients require long-term monitoring.

Coming clean on chlorhexidine-induced dermatoses

Chlorhexidine may induce allergic contact dermatitis or other dermatoses. This should be kept in mind to avoid delay in diagnosis.

Juvenile lichen sclerosus: A loss of innocence

Read the August 17, 2020 DermWorld Insights and Inquiries on juvenile lichen sclerosus.

Reflections on reflectance confocal microscopy for diagnosing benign lichenoid keratoses

Reflectance confocal microscopy may obviate the need for biopsies of benign lichenoid keratoses (and other lesions).

Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease

FcRn antagonists, currently approved for treating myasthenia gravis, show potential for treating pemphigus and other autoimmune diseases.  

Optimizing financial efficiency: Part 3

Experts offer advice on best practices for monitoring and auditing income. ... Feature ... By Megan Bennett, Staff Writer , July 1, 2026 The dermatologist sees their patient, finalizes their notes, closes the chart, and submits their claims. ... However, the revenue cycle is far from over. ... Careful consideration

Propranolol and neutrophilic dermatoses: Can beta-blockade be better blockade?

Read the December 8, 2021 DermWorld Insights and Inquiries on propranolol and neutrophilic dermatoses.

Dermatologic ergonomics: Straighten up and fly right

Ergonomic training should start with residency and continue throughout a career to avoid potentially serious musculoskeletal injury.

Here comes summer (and sunscreen conversations)!

Read the April 29, 2020 DermWorld Insights and Inquiries on suncreen.

A slippery slope

Non-physician providers seek authority to perform cosmetic medical procedures, threatening patient safety and the value of specialty medical training ... Feature ... By Allison Evans, Assistant Managing Editor, May 1, 2022 The Academy has been monitoring and responding to a variety of proposals and bills in the aesthetic arena that

Battling scope expansions in Colorado

Ask the Expert ... By Victoria Houghton, Managing Editor, June 1, 2022 DermWorld spoke to Geoffrey Lim, MD, FAAD, legislative trustee for the Colorado Dermatologic Society Executive Board, about its efforts with the American Academy of Dermatology Association (AADA) to advocate against state scope of practice expansions. DermWorld: In a

Eye-opening news about oxymetazoline

Read the April 27, 2022 DermWorld Insights and Inquiries on eye-opening news about oxymetazoline.

Clinical and therapeutic judgment regarding confluent and reticulated papillomatosis of Gougerot and Carteaud

Confluent and Reticulated Papillomatosis of Gougerot and Carteaud is usually seen in adolescents and young adults. Antibiotics (most commonly minocycline or doxycycline) are first-line therapy. The etiology of CARP remains to be determined, and further studies will judge its precise relationship to acanthosis nigricans.

Keeping abreast of drug-induced cutaneous lupus

Read the August 4, 2021 DermWorld Insights and Inquiries on drug-induced cutaneous lupus.

The naked truth about total body skin examination: A lesson from Goldilocks and the Three Bears

By Lorraine L. Rosamilia, MD Nov. 13, 2019 Vol. 1, No. 36 In my last 13 years of immersion in dermatology, I have often asked this simple yet elusive question of my superiors, my colleagues, and myself: Which patients need skin checks? As I peruse my clinical schedule, in which

Human papillomavirus 42: Putting a finger on the pathogenesis of digital papillary adenocarcinomas

DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, July 1, 2026 Vol. 8, No. 7 Lumps and bumps make me nervous, especially when presented as a "by the way, while I’m here, what do you think of this?" lesion. I’ll ask a few questions: "How long has

Running dry

Identifying the steps needed to ease the looming physician workforce shortage ... Feature ... By Ruth Carol, Contributing Writer, December 1, 2021 For years, there has been concern that a physician workforce shortage is looming. The United States could see a shortfall of 37,800 to 124,000 physicians by 2034, according

Always another worry for patients with hidradenitis suppurativa: Amyloid A amyloidosis

For patients with chronic hidradenitis suppurativa, a simple urinalysis can screen for renal amyloidosis, the most common manifestation of amyloid A amyloidosis.

A seasoned approach to treating the “salt and pepper” dyspigmentation of systemic sclerosis

Read the Feb. 1, 2023 DermWorld Insights and Inquiries on treating the “salt and pepper” dyspigmentation of systemic sclerosis.

Seeing red with dupilumab

Read the March 1, 2023 DermWorld Insights and Inquiries on seeing red with dupilumab.

The expanding horizon of anti-IL-36 therapy

The IL-36/IL-36R axis is crucial in the pathogenesis and treatment of generalized pustular psoriasis. Researchers have demonstrated that this pathway may be instrumental in several other inflammatory dermatoses, as already shown in pyoderma gangrenosum.

Your Dermatologist Knows

An update on the Academy’s successful consumer positioning strategy. ... Feature ... By Matt Walsh, Specialist, Member Communications, December 1, 2025 2026 will be the fourth full year of the Academy’s revolutionary push to position board-certified dermatologists as the experts in skin, hair, and nail health. Since launching in October

Metformin mania: Is it an adequate chemopreventive agent for skin cancer?

Read the Aug. 31, 2022 DermWorld Insights and Inquiries on metformin as a chemopreventive agent for skin cancer.

Caveat mTOR revisited: Neurofibromatosis

Targeting the MAPK/ERK and PI3K/AKT/mTOR pathway has led to the use of topical sirolimus for neurofibromas and oral selumetinib for children with plexiform neurofibromas.

Hard questions about subcutaneous fat necrosis of the newborn and hypercalcemia

The most important complication of subcutaneous fat necrosis of the newborn is hypercalcemia. Recent studies suggest that it may be more common than previously reported.

A checkup on immune checkpoint inhibitor-induced subacute cutaneous lupus

Read the March 15, 2023 DermWorld Insights and Inquiries on immune checkpoint inhibitor-induced subacute cutaneous lupus.

Pathway to reducing medical errors

Although the overall error rate may be low, there are specific areas and opportunities to further reduce errors in the diagnostic pathway. Being vigilant and recognizing steps prone to errors facilitates detecting errors before any potential harm comes to the patient.

Managing menopause

Dermatologists discuss dermatologic changes before and during menopause and the dermatoses that may occur. ... Feature ... By Allison Evans, Assistant Managing Editor, December 1, 2025 Menopausal transitions can be stressful. While rapidly declining estrogen levels can wreak havoc internally, many of these changes involve the skin, hair, and vulvar

Keeping pace

Life-changing advances and a multidisciplinary approach give new hope to patients with Merkel cell carcinoma ... Feature ... By Allison Evans, Assistant Managing Editor, November 1, 2021 When Paul Nghiem, MD, PhD, FAAD, first started treating patients with skin cancer almost 20 years ago, physicians had little understanding of how

Pediatric diseases in disguise

Dermatologists discuss conditions that may be harder to diagnose in children. ... Feature ... By Allison Evans, Assistant Managing Editor, October 1, 2025 Despite years of rigorous training and experience, even the best dermatologists may miss a pediatric diagnosis, particularly for dermatologists who don’t see as many pediatric patients. Some

From Down Under to all over: Kava-induced cutaneous adverse reactions

As kava use increases, dermatologists should recognize the acute sebotropic eruption that may be accompanied by systemic symptoms. Classic kava dermopathy is a reversible acquired ichthyosis associated with heavy kava use.

COVID-19 and dermatology

What have we learned about the cutaneous manifestations of the virus and the vaccines? ... Feature ... By Emily Margosian, Assistant Editor, December 1, 2021 While the immediate and long-term effects of COVID-19 on the human body are still being studied, new research regarding the cutaneous manifestations of the virus

Sky high

PBM tactics increase drug prices, lower patient access ... Feature ... By Ruth Carol, Contributing Writer, September 1, 2022 Last month, ... DermWorld discussed the role pharmacy benefits managers (PBMs) play in the drug distribution chain. This month, we will discuss some of the tactics PBMs use that are driving

Embracing change

Go to AAD Home ... Go to AAD Home ... Menu ... Strategies to help dermatologists adapt – and be happy about it ... Strategies to help dermatologists adapt – and be happy about it ... By Ruth Carol, contributing writer It seems as if a day doesn’t go by

The not-so-full body skin examination

Full body skin examinations (FBSEs) are an increasing component of daily practice. The term “full” is often a misnomer. The issues of appropriateness and societal cost of FBSEs need further scrutiny.